Skip to content

TRDA · Entrada Therapeutics, Inc.

Healthcare · −8.6% on Oct 16

☆ Add to watchlist

Updated Oct 17 · 6 feeds behind: Insider filings, 3 days, and 5 more · Every feed →

On this page

The market view

Price chart

The interactive TRDA chart (by TradingView) loads here.

Our take

1 rule fired on TRDA

In short: none of these rules has solid or some evidence yet, so they show no clear lean on TRDA.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

The 0–100 score for TRDA, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on TRDA, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Compare with this company’s history

Is disclosure activity unusual?

See how many different insiders or members of Congress reported purchases or sales of TRDA. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.

Latest period: Sep 22, 2026–Oct 19, 2026 · UTC dates · today is excluded

Insider purchases

Short history

Only 1 earlier period is on file to compare with. We need at least 6 full periods before calling a count unusual.

Latest 28 days
0
Earlier median
0
Earlier range
0–0
Distinct filers per 28 daysScale: 0–1
Oct 21, 2025Oct 19, 2026
Earlier periodsLatest 28 daysEarlier median 0Limited or missing history

Who appears in the latest period?

No named filers on file for this period.

Up to three filers; one example disclosure each.

Inspect this period’s filings

The history behind this view

First stored company disclosure: Aug 3, 2026. Newest disclosure across this feed: Oct 16, 2026.

Earlier periods in the comparison: 1. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.

Exact counts, dates and filings for all four categories
Insider purchases · Short history

Only 1 earlier period is on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 0; range: 0–0.

Insider purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 21, 2025–Nov 17, 2025—Unavailable
Nov 18, 2025–Dec 15, 2025—Unavailable
Dec 16, 2025–Jan 12, 2026—Unavailable
Jan 13, 2026–Feb 9, 2026—Unavailable
Feb 10, 2026–Mar 9, 2026—Unavailable
Mar 10, 2026–Apr 6, 2026—Unavailable
Apr 7, 2026–May 4, 2026—Unavailable
May 5, 2026–Jun 1, 2026—Unavailable
Jun 2, 2026–Jun 29, 2026—Unavailable
Jun 30, 2026–Jul 27, 2026—Unavailable
Jul 28, 2026–Aug 24, 20260Partial; excluded
Aug 25, 2026–Sep 21, 20260Within stored history
Sep 22, 2026–Oct 19, 2026Latest period0Within stored history
Insider sales · Short history

Only 1 earlier period is on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 13; range: 13–13.

Insider sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 21, 2025–Nov 17, 2025—Unavailable
Nov 18, 2025–Dec 15, 2025—Unavailable
Dec 16, 2025–Jan 12, 2026—Unavailable
Jan 13, 2026–Feb 9, 2026—Unavailable
Feb 10, 2026–Mar 9, 2026—Unavailable
Mar 10, 2026–Apr 6, 2026—Unavailable
Apr 7, 2026–May 4, 2026—Unavailable
May 5, 2026–Jun 1, 2026—Unavailable
Jun 2, 2026–Jun 29, 2026—Unavailable
Jun 30, 2026–Jul 27, 2026—Unavailable
Jul 28, 2026–Aug 24, 20267Partial; excluded
Aug 25, 2026–Sep 21, 202613Within stored history
Sep 22, 2026–Oct 19, 2026Latest period0Within stored history
Congress purchases · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 21, 2025–Nov 17, 2025—Unavailable
Nov 18, 2025–Dec 15, 2025—Unavailable
Dec 16, 2025–Jan 12, 2026—Unavailable
Jan 13, 2026–Feb 9, 2026—Unavailable
Feb 10, 2026–Mar 9, 2026—Unavailable
Mar 10, 2026–Apr 6, 2026—Unavailable
Apr 7, 2026–May 4, 2026—Unavailable
May 5, 2026–Jun 1, 2026—Unavailable
Jun 2, 2026–Jun 29, 2026—Unavailable
Jun 30, 2026–Jul 27, 2026—Unavailable
Jul 28, 2026–Aug 24, 2026—Unavailable
Aug 25, 2026–Sep 21, 2026—Unavailable
Sep 22, 2026–Oct 19, 2026Latest period—Unavailable
Congress sales · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 21, 2025–Nov 17, 2025—Unavailable
Nov 18, 2025–Dec 15, 2025—Unavailable
Dec 16, 2025–Jan 12, 2026—Unavailable
Jan 13, 2026–Feb 9, 2026—Unavailable
Feb 10, 2026–Mar 9, 2026—Unavailable
Mar 10, 2026–Apr 6, 2026—Unavailable
Apr 7, 2026–May 4, 2026—Unavailable
May 5, 2026–Jun 1, 2026—Unavailable
Jun 2, 2026–Jun 29, 2026—Unavailable
Jun 30, 2026–Jul 27, 2026—Unavailable
Jul 28, 2026–Aug 24, 2026—Unavailable
Aug 25, 2026–Sep 21, 2026—Unavailable
Sep 22, 2026–Oct 19, 2026Latest period—Unavailable
How to read this comparison

The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.

Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.

These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

Insiders

Owners & lobbying

All 35 records in this snapshot
  1. Filed
  2. Filed
  3. Filed
  4. Filed
  5. Disclosed
    Ansbert Gadicke · Sale

    Transaction dated Sep 9, 2026

  6. Disclosed
    Ansbert Gadicke · Sale

    Transaction dated Sep 8, 2026

  7. Disclosed
    Luke Evnin · Sale

    Transaction dated Sep 8, 2026

  8. Disclosed
  9. Disclosed
  10. Disclosed
  11. Disclosed
  12. Disclosed
  13. Disclosed
    MPM BioVentures 2014 (B), L.P. · Sale

    Transaction dated Sep 8, 2026

  14. Disclosed
    MPM BioVentures 2014 (B), L.P. · Sale

    Transaction dated Sep 9, 2026

  15. Disclosed
    MPM BioVentures 2014 GP LLC · Sale

    Transaction dated Sep 8, 2026

  16. Disclosed
    MPM BioVentures 2014 LLC · Sale

    Transaction dated Sep 4, 2026

  17. Disclosed
    MPM BioVentures 2014, L.P. · Sale

    Transaction dated Sep 8, 2026

  18. Disclosed
    MPM BioVentures 2014, L.P. · Sale

    Transaction dated Sep 4, 2026

  19. Disclosed
    Mpm Bioventures 2018 (B), L.P. · Sale

    Transaction dated Sep 9, 2026

  20. Disclosed
    MPM BioVentures 2018 GP LLC · Sale

    Transaction dated Sep 8, 2026

  21. Disclosed
    MPM BioVentures 2018 GP LLC · Sale

    Transaction dated Sep 9, 2026

  22. Disclosed
    MPM BioVentures 2018 GP LLC · Sale

    Transaction dated Sep 4, 2026

  23. Disclosed
    MPM BioVentures 2018 LLC · Sale

    Transaction dated Sep 8, 2026

  24. Disclosed
    MPM BioVentures 2018 LLC · Sale

    Transaction dated Sep 4, 2026

  25. Disclosed
    MPM BioVentures 2018 LLC · Sale

    Transaction dated Sep 9, 2026

  26. Disclosed
    Mpm Bioventures 2018, L.P. · Sale

    Transaction dated Sep 4, 2026

  27. Disclosed
    Mpm Bioventures 2018, L.P. · Sale

    Transaction dated Sep 8, 2026

  28. Disclosed
    Mpm Bioventures 2018, L.P. · Sale

    Transaction dated Sep 9, 2026

  29. Disclosed
    Todd Foley · Sale

    Transaction dated Sep 9, 2026

  30. Filed
  31. Filed
  32. Filed
  33. Filed
  34. Filed
  35. Filed

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

No Congress trades on TRDA disclosed in the last 90 days.

See every Congress trade on TRDA →

Company insiders

0 buys · 66 sells (185 filed lots) · $56.1M sold

  1. ▼ SELLMPM BioVentures 2014 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  2. ▼ SELLMPM BioVentures 2014, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  3. ▼ SELLMPM BioVentures 2014 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  4. ▼ SELLMpm Asset Management Investors Bv2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late
  5. ▼ SELLMPM BioVentures 2018 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  6. ▼ SELLMPM BioVentures 2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  7. ▼ SELLAnsbert Gadicke 10% ownerTRDA Entrada Therapeutics, Inc.$206Kdisclosed Sep 9 · filed the same day
  8. ▼ SELLMPM BioVentures 2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late
  9. ▼ SELLMpm Asset Management Investors Bv2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  10. ▼ SELLMPM BioVentures 2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late
See every insider trade on TRDA →

Big holders (Schedule 13D / 13G): 1 filing in the last 90 days · newest: MPM BioVentures 2014, L.P. (13D amendment), Sep 10, 2026 ↗

Filings & events

Company filings (8-K) 59

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Quarterly or yearly results · item 2.0210
  • Other events · item 8.018
  • Shared information with investors · item 7.017
  • Directors or officers joined, left or got new pay · item 5.025
  • Shareholder vote results · item 5.074
  • Signed a major agreement · item 1.013

Filing red flags 22

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

Planned insider sales (Form 144) 51

Notices insiders file before they sell certain shares, such as ones they got straight from the company.

2 in the last 90 days · 51 notices on file

The notices on file don't give the sale's size; each sale shows up under company insiders once it is reported.

5% owners (13D / 13G) 5

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13D, may push for changes: 2 filings
  • 13G, just holds: 3 filings

Filed by MPM BioVentures 2014, L.P. · TCG Crossover GP I, LLC · 5AM Ventures V, L.P. · Janus Henderson Group PLC

Biggest named funds (13F)

The largest TRDA holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on TRDA

  1. ▼ SELLMPM BioVentures 2014 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  2. ▼ SELLMPM BioVentures 2014, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  3. ▼ SELLMPM BioVentures 2014 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  4. ▼ SELLMpm Asset Management Investors Bv2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late
  5. ▼ SELLMPM BioVentures 2018 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  6. ▼ SELLMPM BioVentures 2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  7. ▼ SELLAnsbert Gadicke 10% ownerTRDA Entrada Therapeutics, Inc.$206Kdisclosed Sep 9 · filed the same day
  8. ▼ SELLMPM BioVentures 2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late
  9. ▼ SELLMpm Asset Management Investors Bv2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  10. ▼ SELLMPM BioVentures 2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late
  11. ▼ SELLMpm Bioventures 2018, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late
  12. ▼ SELLMPM BioVentures 2018 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$206Kdisclosed Sep 9 · filed the same day
  13. ▼ SELLMpm Bioventures 2018, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  14. ▼ SELLMPM BioVentures 2014, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late
  15. ▼ SELLMPM Asset Management Investors BV2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$206Kdisclosed Sep 9 · filed the same day
  16. ▼ SELLMpm Bioventures 2018 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$206Kdisclosed Sep 9 · filed the same day
  17. ▼ SELLAnsbert Gadicke 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  18. ▼ SELLMpm Asset Management Investors Bv2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$206Kdisclosed Sep 9 · filed the same day
  19. ▼ SELLMpm Bioventures 2018, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$206Kdisclosed Sep 9 · filed the same day
  20. ▼ SELLMPM BioVentures 2014 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$206Kdisclosed Sep 9 · filed the same day
  21. ▼ SELLMPM Asset Management Investors BV2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  22. ▼ SELLMPM BioVentures 2018 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late
  23. ▼ SELLTodd Foley 10% ownerTRDA Entrada Therapeutics, Inc.$206Kdisclosed Sep 9 · filed the same day
  24. ▼ SELLLuke Evnin 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  25. ▼ SELLMPM BioVentures 2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$206Kdisclosed Sep 9 · filed the same day
See all 185 trades on TRDA →
People & votes

Which members of Congress traded TRDA, sponsored bills that touch it and voted on them — opens here.